Prelude Therapeutics Inc PRLD:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/20/24 EDT
4.12quote price arrow up+0.12 (+3.00%)
Volume
21,605
52 week range
1.66 - 6.03
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close4.12
  • 52 Week High6.03
  • 52 Week High Date06/06/23
  • 52 Week Low1.66
  • 52 Week Low Date11/01/23

Key Stats

  • Market Cap226.31M
  • Shares Out54.93M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta1.56
  • YTD % Change-3.51

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close4.12
  • 52 Week High6.03
  • 52 Week High Date06/06/23
  • 52 Week Low1.66
  • 52 Week Low Date11/01/23
  • Market Cap226.31M
  • Shares Out54.93M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta1.56
  • YTD % Change-3.51

RATIOS/PROFITABILITY

  • EPS (TTM)-1.88
  • P/E (TTM)-2.19
  • Fwd P/E (NTM)-2.36
  • EBITDA (TTM)-136.188M
  • ROE (TTM)-65.04%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/01/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Prelude Therapeutics Inc

 

Profile

MORE
Prelude Therapeutics Incorporated is a clinical-stage fully integrated oncology company built on a foundation of drug discovery to deliver novel precision cancer medicines to underserved patients. It has developed a diverse pipeline consisting of multiple distinct programs: kinases, targeted protein degraders, and precision antibody drug conjugates. Its product candidates include PRT3789, PRT2527 and PRT3645. PRT3789 is a highly selective degrader of SMARCA2 protein, which...
Paul Friedman M.D.
Independent Chairman of the Board
Krishna Vaddi Ph.D.
Chief Executive Officer, Founder, Director
Jane Huang M.D.
President, Chief Medical Officer
Bryant Lim J.D.
Interim Chief Financial Officer, Chief Legal Officer and Corporate Secretary
Andrew Combs Ph.D.
Executive Vice President, Head of Chemistry
Address
175 Innovation Boulevard
Wilmington, DE
19805
United States

Top Peers

SYMBOLLASTCHG%CHG
ZURA
Zura Bio Ltd
5.99-0.06-0.99%
CRVO
CervoMed Inc
19.74-4.35-18.06%
ABOS
Acumen Pharmaceuticals Inc
3.84+0.19+5.21%
INMB
INmune Bio Inc
11.23+0.38+3.50%
OVID
Ovid Therapeutics Inc
3.14-0.01-0.32%